Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Actinium Pharmaceuticals Inc. (ATNM)

0.2042   -0.007 (-3.18%) 11-19 16:00
Open: 0.21 Pre. Close: 0.2109
High: 0.215 Low: 0.2
Volume: 1,608,750 Market Cap: 34M
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.22 - 0.222 0.222 - 0.223
Low: 0.197 - 0.198 0.198 - 0.2
Close: 0.207 - 0.21 0.21 - 0.212

Technical analysis

as of: 2019-11-19 4:24:22 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.38     One year: 0.48
Support: Support1: 0.20    Support2: 0.16
Resistance: Resistance1: 0.33    Resistance2: 0.41
Pivot: 0.25
Moving Average: MA(5): 0.23     MA(20): 0.26
MA(100): 0.23     MA(250): 0.35
MACD: MACD(12,26):     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 13.84     %D(3): 17.29
RSI: RSI(14): 39.70
52-week: High: 0.71  Low: 0.19  Change(%): -50.4
Average Vol(K): 3-Month: 150398  10-Days: 102888

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ATNM has closed below the lower band by 6.8%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 34% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Actinium Pharmaceuticals to Present at the 25th Annual BIO-Europe® 2019 International Partnering Conference
NEW YORK , Nov. 7, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") announced today that it will attend the 25 th Annual BIO-Europe ® International Partnering …

Actinium Announces Interim Results from Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML Accepted for Presentation at ASH 2019
NEW YORK, Nov. 6, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that interim results from a Phase 1 trial studying Actimab-A in combination with CLAG-M have been accepted for presentation at the 2019 American Society of Hematology (ASH

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 164.70
Shares Float (M) 154.22
% Held by Insiders 1.30
% Held by Institutions 12.47
Shares Short (K) 3510
Shares Short P. Month (K)

Stock Financials

EPS -0.173
Book Value (p.s.) 0.060
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -92.9
Return on Equity (ttm) -219.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.143
Qtrly Earnings Growth
Operating Cash Flow (M) -20.74
Levered Free Cash Flow (M) -12.24

Stock Valuations

P/E -1.19
P/E Growth Ratio -0.02
P/BV 3.43
P/CF -1.63

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.